585517-09-5 Usage
Uses
Used in Pharmaceutical Research:
CHEMBRDG-BB 6606817 is used as a research compound for the development of potential drug candidates targeting central nervous system (CNS) disorders. Its ability to penetrate the blood-brain barrier makes it a valuable asset in the discovery and development of new therapeutic agents for various neurological conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, CHEMBRDG-BB 6606817 is utilized for further investigation and development of its pharmacological properties. Its unique structure and molecular composition provide a foundation for understanding its interactions with biological targets and potential therapeutic effects.
Used in Drug Discovery:
CHEMBRDG-BB 6606817 plays a crucial role in drug discovery, where its properties and potential activities are explored to identify new therapeutic agents. Its BBB penetration capability and benzoylguanidine derivative nature make it a promising candidate for the development of innovative treatments for CNS disorders.
Used in CNS Disorder Treatment:
CHEMBRDG-BB 6606817 is used as a potential therapeutic agent for the treatment of central nervous system disorders. Its ability to cross the blood-brain barrier allows for targeted delivery of the compound to the affected areas, potentially leading to improved treatment outcomes for patients suffering from neurological conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 585517-09-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,5,5,1 and 7 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 585517-09:
(8*5)+(7*8)+(6*5)+(5*5)+(4*1)+(3*7)+(2*0)+(1*9)=185
185 % 10 = 5
So 585517-09-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H12ClNO2/c12-9-7-8(11(14)15)3-4-10(9)13-5-1-2-6-13/h3-4,7H,1-2,5-6H2,(H,14,15)
585517-09-5Relevant articles and documents
4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME
-
Paragraph 0474-0478; 0485-0488, (2020/02/08)
An object of the present invention is to provide a compound or a salt thereof having anti-HBV activity, a pharmaceutical composition, an anti-hepatitis B virus agent, a production inhibitor of DNA of a hepatitis B virus, and a production or secretion inhibitor of a hepatitis B surface antigen. According to the present invention, provided are a compound represented by General Formula [1] or a salt thereof: (in the formula, R1 represents a benzothiazolyl group which may be substituted (in which a carbon atom constituting the 6-membered ring of the benzothiazolyl group of R1 is bonded to the nitrogen atom of the pyridone ring); R2 represents a C2-6 alkenyl group which may be substituted, or the like; and R3 represents a hydrogen atom or the like).
OXADIAZOLE SUBSTITUTED INDAZOLE DERIVATIVES FOR USE AS SPHINGOSINE 1-PHOSPHATE (S1P) AGONISTS
-
Page/Page column 59-60, (2008/12/08)
The present invention provides compounds of formula (I) or salts thereof, having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.
